Gene Transfer of Interleukin 10 to the Murine Cornea Using Electroporation

Abstract

Gene therapy is a promising approach to deliver anti-inflammatory genes to the eye to treat a number of corneal diseases. We have used electroporation to deliver plasmids expressing interleukin 10 (IL-10) to the corneas of mice and evaluated the duration of expression following gene transfer. Unlike expression of reporter genes driven from the cytomegalovirus immediate early promoter (CMV_iep), which remained high for 3 days, CMV_iep-driven IL-10 expression peaked at Day 1 and decreased 2-fold each day thereafter. In an attempt to increase the duration of expression, the long-acting ubiquitin C (UbC) promoter was used but, surprisingly, a similar half-life of gene expression was observed. This reduced duration was not due to promoter inhibition by expressed IL-10 or clearance of plasmids from the cornea. However, when DNA nuclear targeting sequences (DTSs) that promote DNA nuclear import were removed from the plasmids, contrary to findings in nondividing cells and tissues in which these sequences are needed for gene transfer, robust expression was observed, and the duration increased significantly. Although corneal cell turnover was detected, suggesting mitosis-dependent plasmid nuclear localization independent of a DTS, the patterns of expressing and dividing cells appeared different. These results suggest that DNA nuclear targeting sequences may act differently in the cornea than in other tissues.

Get full access to this article

View all access options for this article.

References

Mohan RR, Sharma A, Netto MV, Sinha S, Wilson SE. Gene therapy in the cornea. Prog Retin Eye Res 24:537–559, 2005.

Wiggs JL, Haines JL, Paglinauan C, Fine A, Sporn C, Lou D. Genetic linkage of autosomal dominant juvenile glaucoma to chromosome 1q21-q31 in three affected pedigrees. Genomics 21:299–303, 1994.

Sheffield VC, Stone EM, Alward WL, Drack AV, Johnson AT, Streb LM, Nichols BE. Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31. Nat Genet 4:47–50, 1993.

Eiberg H, Lund AM, Warburg M, Rosenberg T. Assignment of congenital cataract Volkmann type (CCV) to chromosome 1p36. Hum Genet 9:33–38, 1995.

Rodriguez IR, Gonzalez P, Zigler Jr. JS, Borrás TA. A guinea pig hereditary cataract contains a splice site deletion in a crystallin gene. Biochim Biophys Acta 1180:44–52, 1992.

Bron AJ. Genetics of the corneal dystrophies: what we have learned in the past twenty-five years. Cornea 19:699–711, 2000.

Biswas S, Munier FL, Yardley J, Hart-Holden N, Perveen R, Cousin P, Sutphin JE, Noble B, Batterbury M, Kielty C, Hackett A, Bonshek R, Ridgway A, McLeod D, Sheffield VC, Stone EM, Schorderet DF, Black GC. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet 10:2415–2423, 2001.

Tumpey TM, Cheng H, Yan X-T, Oakes JE, Lausch RN. Chemokine synthesis in the HSV-1-infected cornea and its suppression by interleukin-10. J Leukoc Biol 63:486–492, 1998.

Tumpey TM, Elner VM, Chen SH, Oakes JE, Lausch RN. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol 153:2258–2265, 1994.

10.

Li L, Elliot JF, Mosmann TR. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 154:5590–5600, 1994.

11.

Daheshia M, Kuklin N, Kanangat S, Manickan E, Rouse BT. Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J Immunol 159: 1945–1952, 1997.

12.

Blair-Parks K, Weston BC, Dean DA. Gene delivery to the cornea by plasmid injection and electroporation. J Gene Med 4:92–100, 2002.

13.

Dean DA. Import of plasmid DNA into the nucleus is sequence specific. Exp Cell Res 230:293–302, 1997.

14.

Dean DA, Dean BS, Muller S, Smith LC. Sequence requirements for plasmid nuclear entry. Exp Cell Res 253:713–722, 1999.

15.

Dean BS, Byrd JN, Jr., Dean DA. Nuclear targeting of plasmid DNA in human corneal cells. Curr Eye Res 19:66–75, 1999.

16.

Blomberg P, Eskandarpour M, Xia S, Sylven C, Islam KB. Electroporation in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle. Biochem Biophys Res Commun 298:505–510, 2002.

17.

Li S, MacLaughlin FC, Fewell JG, Gondo M, Wang J, Nicol F, Dean DA, Smith LC. Muscle-specific enhancement of gene expression by incorporation of the SV40 enhancer in the expression plasmid. Gene Ther 8:494–497, 2001.

18.

Young JL, Benoit JN, Dean DA. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature. Gene Ther 10:1465–1470, 2003.

19.

Vacik J, Dean BS, Zimmer WE, Dean DA. Cell-specific nuclear import of plasmid DNA. Gene Ther 6:1006–1014, 1999.

20.

Hendricks RL, Epstein RJ, Viana MA, Hoffmann DA. A reproducible method for injecting the mouse corneal stroma. Invest Ophthalmol Vis Sci 32:366–370, 1991.

21.

Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 8:1539–1546, 2001.

22.

Klebe S, Sykes PJ, Coster DJ, Krishnan R, Williams KA. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 71:1214–1220, 2001.

23.

Bertelmann E, Ritter T, Vogt K, Reszka R, Hartmann C, Pleyer U. Efficiency of cytokine gene transfer in corneal endothelial cells and organ-cultured corneas mediated by liposomal vehicles and recombinant adenovirus. Ophthalmic Res 35:117–124, 2003.

24.

Chun S, Daheshia M, Lee S, Rouse BT. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy. Cell Immunol 194:194–204, 1999.

25.

Kachi S, Esumi N, Zack DJ, Campochiaro PA. Sustained expression after nonviral ocular gene transfer using mammalian promoters. Gene Ther 13:798–804, 2006.

26.

Zieske JD, Guimaraes SR, Hutcheon AE. Kinetics of keratocyte proliferation in response to epithelial debridement. Exp Eye Res 72:33–39, 2001.

27.

Graessman M, Menne J, Liebler M, Graeber I, Graessman A. Helper activity for gene expression, a novel function of the SV40 enhancer. Nucleic Acids Res 17:6603–6612, 1989.